These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 9790428)

  • 1. A mass chemotherapy trial of praziquantel on Schistosoma haematobium endemicity in Upper Egypt.
    Talaat M; Miller FD
    Am J Trop Med Hyg; 1998 Oct; 59(4):546-50. PubMed ID: 9790428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Annual Praziquantel Treatment on Urogenital Schistosomiasis in a Seasonal Transmission Focus in Central Senegal.
    Senghor B; Diaw OT; Doucoure S; Seye M; Diallo A; Talla I; Bâ CT; Sokhna C
    PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004557. PubMed ID: 27015646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Praziquantel treatment of school children from single and mixed infection foci of intestinal and urogenital schistosomiasis along the Senegal River Basin: monitoring treatment success and re-infection patterns.
    Webster BL; Diaw OT; Seye MM; Faye DS; Stothard JR; Sousa-Figueiredo JC; Rollinson D
    Acta Trop; 2013 Nov; 128(2):292-302. PubMed ID: 23022016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term impact of a mass treatment by praziquantel on morbidity due to Schistosoma haematobium in two hyperendemic villages of Niger].
    Garba A; Campagne G; Tassie JM; Barkire A; Vera C; Sellin B; Chippaux JP
    Bull Soc Pathol Exot; 2004 Feb; 97(1):7-11. PubMed ID: 15104149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Seasonality as a determinant of the efficacy of praziquantel in population-based chemotherapy: lessons from the practice.
    Abu-Elyazeed RR; Mansour NS; Youssef FG; Boghdadi AM; el Khoby TA; Hassanein YA; el Gamal RR
    J Egypt Soc Parasitol; 1998 Apr; 28(1):1-7. PubMed ID: 9617037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Schistosoma haematobium infection and morbidity before and after large-scale administration of praziquantel in Burkina Faso.
    Koukounari A; Gabrielli AF; Toure S; Bosque-Oliva E; Zhang Y; Sellin B; Donnelly CA; Fenwick A; Webster JP
    J Infect Dis; 2007 Sep; 196(5):659-69. PubMed ID: 17674306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessing the benefits of five years of different approaches to treatment of urogenital schistosomiasis: A SCORE project in Northern Mozambique.
    Phillips AE; Gazzinelli-Guimaraes PH; Aurelio HO; Ferro J; Nala R; Clements M; King CH; Fenwick A; Fleming FM; Dhanani N
    PLoS Negl Trop Dis; 2017 Dec; 11(12):e0006061. PubMed ID: 29220347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urine circulating soluble egg antigen in relation to egg counts, hematuria, and urinary tract pathology before and after treatment in children infected with Schistosoma haematobium in Kenya.
    Kahama AI; Odek AE; Kihara RW; Vennervald BJ; Kombe Y; Nkulila T; Hatz CF; Ouma JH; Deelder AM
    Am J Trop Med Hyg; 1999 Aug; 61(2):215-9. PubMed ID: 10463669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and clinical aspects of urogenital schistosomiasis in women, in Burkina Faso, West Africa.
    Zida A; Briegel J; Kabré I; Sawadogo MP; Sangaré I; Bamba S; Yacouba A; Ouédraogo A; Yonli D; Drabo F; Traoré LK; Ouédraogo-Traoré R; Guiguemdé RT; Wacker J
    Infect Dis Poverty; 2016 Sep; 5(1):81. PubMed ID: 27581074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The influence of transmission season on parasitological cure rates and intensity of infection after praziquantel treatment of Schistosoma haematobium-infected schoolchildren in Mozambique.
    Augusto G; Magnussen P; Kristensen TK; Appleton CC; Vennervald BJ
    Parasitology; 2009 Nov; 136(13):1771-9. PubMed ID: 19490727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Praziquantel and oltipraz: the treatment of schoolchildren infected with Schistosoma mansoni and/or Schistosoma haematobium in Gezira, Sudan.
    el Tayeb M; Daffalla AA; Kardaman MW; See R; Fenwick A
    Ann Trop Med Parasitol; 1988 Feb; 82(1):53-7. PubMed ID: 3135786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Day-to-day variation of egg output and schistosome circulating antigens in urine of Schistosoma haematobium-infected school children from Gabon and follow-up after chemotherapy.
    Van Etten L; Kremsner PG; Krijger FW; Deelder AM
    Am J Trop Med Hyg; 1997 Sep; 57(3):337-41. PubMed ID: 9311646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates.
    El-Khoby T; Galal N; Fenwick A; Barakat R; El-Hawey A; Nooman Z; Habib M; Abdel-Wahab F; Gabr NS; Hammam HM; Hussein MH; Mikhail NN; Cline BL; Strickland GT
    Am J Trop Med Hyg; 2000 Feb; 62(2 Suppl):88-99. PubMed ID: 10813505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of reinfection following praziquantel treatment of urinary schistosomiasis at a period of low transmission.
    Ofoezie IE
    Acta Trop; 2000 Feb; 75(1):123-6. PubMed ID: 10708014
    [No Abstract]   [Full Text] [Related]  

  • 15. Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.
    Mutapi F; Ndhlovu PD; Hagan P; Spicer JT; Mduluza T; Turner CM; Chandiwana SK; Woolhouse ME
    J Infect Dis; 1998 Jul; 178(1):289-93. PubMed ID: 9652458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-4, immunoglobulin E and immunoglobulin A and resistance to re-infection with Schistosoma haematobium before and after chemotherapy.
    Khalil HM; Abd el Baki MH; Abd el Mawla MM; Maklad KM; Sharaf SA; Saad AE
    J Egypt Soc Parasitol; 1999 Aug; 29(2):395-408. PubMed ID: 10605492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of passive chemotherapy on Schistosoma mansoni prevalence and intensity of infection in the Egyptian Nile Delta.
    El Sayed MK; Barakat R; Farghaly A; El Badway A; Soliman NK; Husein MH; Miller FD
    Am J Trop Med Hyg; 1997 Sep; 57(3):266-71. PubMed ID: 9311634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morbidity induced by Schistosoma haematobium infections, as assessed by ultrasound before and after treatment with praziquantel, in a recently expanded focus (Senegal River basin).
    Delegue P; Picquet M; Shaw DJ; Vercruysse J; Sambou B; Ly A
    Ann Trop Med Parasitol; 1998 Oct; 92(7):775-83. PubMed ID: 9924535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy and acceptability of praziquantel in the treatment of Schistosoma haematobium in pre-school children of Kwale County, Kenya.
    Kimani BW; Mbugua AK; Kihara JH; Ng'ang'a M; Njomo DW
    PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006852. PubMed ID: 30332403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of Schistosoma haematobium infection, impact of praziquantel treatment and re-infection after treatment in a cohort of schoolchildren from rural KwaZulu-Natal/South Africa.
    Saathoff E; Olsen A; Magnussen P; Kvalsvig JD; Becker W; Appleton CC
    BMC Infect Dis; 2004 Oct; 4():40. PubMed ID: 15471549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.